North American Neuromodulation Market to Grow at a CAGR of 10.6% to reach US$ 6,612.00 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North American Neuromodulation Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North American Neuromodulation Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing Developments in Neuromodulation Technology

5.2 Market Opportunities

5.2.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.3 Future Trends

5.3.1 Technological Advancements

5.4 Impact of Drivers and Restraints

6. North American Neuromodulation Market Regional Analysis

6.1 North American Neuromodulation Market Overview

6.2 North American Neuromodulation Market Revenue 2017-2027 (US$ Million)

6.3 North American Neuromodulation Market Forecast Analysis

7. North American Neuromodulation Market Analysis – by Technology

7.1 External Neuromodulation

7.1.1 Overview
7.1.2 External Neuromodulation: North American Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Internal Neuromodulation

7.2.1 Overview
7.2.2 Internal Neuromodulation: North American Neuromodulation Market – Revenue and Forecast to 2031 (US$ Million)

8. North American Neuromodulation Market Analysis – by Application

8.1 Chronic Pain Management

8.1.1 Overview
8.1.2 Chronic Pain Management: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Failed Back Syndrome

8.2.1 Overview
8.2.2 Failed Back Syndrome: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Epilepsy

8.3.1 Overview
8.3.2 Epilepsy: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Tremor

8.4.1 Overview
8.4.2 Tremor: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Incontinence

8.5.1 Overview
8.5.2 Incontinence: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.6 Depression

8.6.1 Overview
8.6.2 Depression: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.7 Dystonia

8.7.1 Overview
8.7.2 Dystonia: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.8 Gastroparesis

8.8.1 Overview
8.8.2 Gastroparesis: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.9 Parkinson's Disease

8.9.1 Overview
8.9.2 Parkinson's Disease: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.10 Obsessive-Compulsive Disorder

8.10.1 Overview
8.10.2 Obsessive-Compulsive Disorder: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.11 Migraine

8.11.1 Overview
8.11.2 Migraine: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9. North American Neuromodulation Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Migraine: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Migraine: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Home Healthcare

9.3.1 Overview
9.3.2 Migraine: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10. North American Neuromodulation Market – North America Analysis

10.1 North America

10.1.1 North American Neuromodulation Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 North American Neuromodulation Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North American Neuromodulation Market Breakdown, by Technology
10.1.1.1.2 US: North American Neuromodulation Market Breakdown, by Application
10.1.1.1.3 US: North American Neuromodulation Market Breakdown, by End User

10.1.1.2 Canada: North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North American Neuromodulation Market Breakdown, by Technology
10.1.1.2.2 Canada: North American Neuromodulation Market Breakdown, by Application
10.1.1.2.3 Canada: North American Neuromodulation Market Breakdown, by End User

10.1.1.3 Mexico : North American Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North American Neuromodulation Market Breakdown, by Technology
10.1.1.3.2 Mexico : North American Neuromodulation Market Breakdown, by Application
10.1.1.3.3 Mexico : North American Neuromodulation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North American Neuromodulation Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Medtronic

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 NeuroPace, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 NeuroSigma, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 NEVRO CORP.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Synapse Biomedical Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Soterix Medical Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Integer Holdings Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Magstim

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

Abbott
Boston Scientific Corporation
Medtronic
NeuroPace, Inc.
NeuroSigma, Inc.
NEVRO CORP.
Synapse Biomedical Inc.
Soterix Medical Inc
Integer Holdings Corporation

Magstim